HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IS DETERMINED BY EPITOPE EXPOSURE ON THE GP120 OLIGOMER

被引:315
|
作者
SATTENTAU, QJ [1 ]
MOORE, JP [1 ]
机构
[1] NYU,SCH MED,AARON DIAMOND AIDS RES CTR,NEW YORK,NY 10016
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1995年 / 182卷 / 01期
关键词
D O I
10.1084/jem.182.1.185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The major target of the neutralizing antibody response to infection by the human immunodeficiency virus type 1 (HIV-1) is the outer envelope glycoprotein, gp120. The spectrum of HIV-1 neutralization specificity is currently represented by monoclonal antibodies (mAbs) that can be divided broadly into five groups. We have studied the binding of these mAbs to functional oligomeric and soluble monomeric gp120 derived from the molecular clone of a cell line-adapted isolate of HIV-1, and compared these binding properties with virus neutralization. Binding of all mAbs except those reactive with the V3 loop was much weaker to oligomeric than to monomeric gp120. This reduction in binding to oligomeric gp120 was determined mostly by a slower relative rate of association, although the dissociation rate also had some influence on relative variation in mAb affinity. Virus neutralization correlated broadly with mAb binding to the oligomeric rather than to the monomeric form of gp120, and neutralization potency was related to the estimated association rate. Thus, with the exception of the hypervariable V3 loop, regions of HIV-1 gp120 with the potential to induce a neutralization response are likely to be poorly presented for antibody recognition on the surface of cell line-adapted virions.
引用
收藏
页码:185 / 196
页数:12
相关论文
共 50 条
  • [21] CHARACTERIZATION OF MUTANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT HAVE ESCAPED NEUTRALIZATION BY A MONOCLONAL-ANTIBODY TO THE GP120 V2 LOOP
    YOSHIYAMA, H
    MO, HM
    MOORE, JP
    HO, DD
    JOURNAL OF VIROLOGY, 1994, 68 (02) : 974 - 978
  • [22] RESISTANCE TO NEUTRALIZATION BY BROADLY REACTIVE ANTIBODIES TO THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 GLYCOPROTEIN CONFERRED BY A GP41 AMINO-ACID CHANGE
    THALI, M
    CHARLES, M
    FURMAN, C
    CAVACINI, L
    POSNER, M
    ROBINSON, J
    SODROSKI, J
    JOURNAL OF VIROLOGY, 1994, 68 (02) : 674 - 680
  • [23] INDUCTION OF INTERLEUKIN-10 BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND ITS GP120 PROTEIN IN HUMAN MONOCYTES MACROPHAGES
    BORGHI, P
    FANTUZZI, L
    VARANO, B
    GESSANI, S
    PUDDU, P
    CONTI, L
    CAPOBIANCHI, MR
    AMEGLIO, F
    BELARDELLI, F
    JOURNAL OF VIROLOGY, 1995, 69 (02) : 1284 - 1287
  • [24] CONSTRUCTION OF A BINDING-SITE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 IN RAT CD4
    SCHOCKMEL, GA
    SOMOZA, C
    DAVIS, SJ
    WILLIAMS, AF
    HEALEY, D
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01): : 301 - 304
  • [25] ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION BY ANTISERA TO PEPTIDES FROM THE ENVELOPE GLYCOPROTEINS GP120/GP41
    JIANG, S
    LIN, K
    NEURATH, AR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06): : 1557 - 1563
  • [26] INTRACEREBRAL INJECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 COAT GLYCOPROTEIN GP120 DOES NOT PRODUCE NEURODEGENERATION IS RATS
    BAGETTA, G
    FINAZZIAGRO, A
    PALMA, E
    NISTICO, G
    NEUROSCIENCE LETTERS, 1994, 176 (01) : 97 - 100
  • [27] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 ENVELOPE GLYCOPROTEIN REGIONS IMPORTANT FOR ASSOCIATION WITH THE GP41 TRANSMEMBRANE GLYCOPROTEIN
    HELSETH, E
    OLSHEVSKY, U
    FURMAN, C
    SODROSKI, J
    JOURNAL OF VIROLOGY, 1991, 65 (04) : 2119 - 2123
  • [28] Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120
    Kirchherr, Jennifer L.
    Hamilton, Jennifer
    Lu, Xiaozhi
    Gnanakaran, S.
    Muldoon, Mark
    Daniels, Marcus
    Kasongo, Webster
    Chalwe, Victor
    Mulenga, Chanda
    Mwananyanda, Lawrence
    Musonda, Rosemary M.
    Yuan, Xing
    Montefiori, David C.
    Korber, Bette T.
    Haynes, Barton F.
    Gao, Feng
    VIROLOGY, 2011, 409 (02) : 163 - 174
  • [29] Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120
    Susal, C
    Kirschfink, M
    Kropelin, M
    Daniel, V
    Opelz, G
    BLOOD, 1996, 87 (06) : 2329 - 2336
  • [30] NEUTRALIZATION SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS DETERMINED IN PART BY THE CELL IN WHICH THE VIRUS IS PROPAGATED
    SAWYER, LSW
    WRIN, MT
    CRAWFORDMIKSZA, L
    POTTS, B
    WU, YM
    WEBER, PA
    ALFONSO, RD
    HANSON, CV
    JOURNAL OF VIROLOGY, 1994, 68 (03) : 1342 - 1349